Takeda's ORZEYFUL (oveporexton) Launches Simultaneously in Japan and China Giving Physicians First Access to Prescribe Novel Orexin Agonist to Patients with Narcolepsy Type 1
One daysingle sourceOne outlet reported this, once - no second voice in this corpus.
All 1 reports on Thu, 15 October 2026
What it is about
Giles PlatfordTsuyoshi TadaChristopher OreillyUnited StatesJapan Ministry Of HealthExchange CommissionChina National Medical Products AdministrationHealth AuthorityDrug AdministrationHealth DrugTakeda Pharmaceutical Company Limited TakedaJapaneseOsaka, Osaka, JapanJapanChina
Who published it, and when
How it spread - 1 original report
Thu, 15 October 2026
1 report- theobserver.ca00:40first to report
− ORZEYFUL is now available in Japan and China following approvals within a month of each other by China’s National Medical Products Administration